Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit while breastfeeding. We will also discuss about common side effects and warnings associated with Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit.

What is Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit used for?


Lo-Zumandimine is an estrogen/progestin COC, indicated for use by women to: Prevent pregnancy. (1.1) Treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception. (1.2) Treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control. (1.3) 1.1 Oral Contraceptive Lo-Zumandimineā„¢ is indicated for use by women to prevent pregnancy. 1.2 Premenstrual Dysphoric Disorder (PMDD) Lo-Zumandimine is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception. The effectiveness of Lo-Zumandimine for PMDD when used for more than three menstrual cycles has not been evaluated. The essential features of PMDD according to the Diagnostic and Statistical Manual-4th edition (DSM-IV) include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. Other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. Physical symptoms associated with PMDD include breast tenderness, headache, joint and muscle pain, bloating and weight gain. In this disorder, these symptoms occur regularly during the luteal phase and remit within a few days following onset of menses; the disturbance markedly interferes with work or school, or with usual social activities and relationships with others. Diagnosis is made by healthcare providers according to DSM-IV criteria, with symptomatology assessed prospectively over at least two menstrual cycles. In making the diagnosis, care should be taken to rule out other cyclical mood disorders. Lo-Zumandimine has not been evaluated for the treatment of premenstrual syndrome (PMS). 1.3 Acne Lo-Zumandimine is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. Lo-Zumandimine should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control.

Is Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit low risk for breastfeeding
Drospirenone and Ethinyl estradiol are the two main ingredients of Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit. Based on our individual analysis of Drospirenone and Ethinyl estradiol we can safely say that Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit has low risk while breastfeeding. Below we have summarized the usage of Drospirenone and Ethinyl estradiol while breastfeeding, we recommend you to go through it for better understanding of your usage.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers When possible, advise the nursing mother to use other forms of contraception until she has weaned her child. Estrogen-containing COCs can reduce milk production in breastfeeding mothers. This is less likely to occur once breastfeeding is well-established; however, it can occur at any time in some women. Small amounts of oral contraceptive steroids and/or metabolites are present in breast milk. After oral administration of 3 mg DRSP/0.03 mg EE (Yasmin) tablets, about 0.02% of the DRSP dose was excreted into the breast milk of postpartum women within 24 hours. This results in a maximal daily dose of about 0.003 mg DRSP in an infant.

Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit Breastfeeding Analsys


Drospirenone while Breastfeeding

Low Risk

Is Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit safe while breastfeeding

Birth control pill that contains the combination of an estrogen (Ethinyl estradiol) and a progestin (Drospirenone) for oral use. Ethinylestradiol is a synthetic estrogen with similar action than estradiol. Used in combination with progestogens for contraception.Ethinylestradiol is excreted into the breast milk in no or small amount.There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of ethinyl estradiol.It may reduce the protein content of the milk.No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. Drospirenone is an analogue of spironolactone which has the effects of progesterone. It is excreted into breast milk in clinically non-significant amount. With other similar combined contraceptives no differences have been observed in the frequency of breastfeeding or the amount of milk produced or weight gain of breastfed infants compared to other contraceptive methods (intrauterine devices, isolated progestogens). However, it would be advisable to avoid them until breastfeeding is well established (4-6 weeks). During lactation, progestin-only contraceptive pills are preferred to Estrogen containing ones, otherwise, the lowest estrogen dose should be used.During the first 6 postpartum weeks, non-hormonal methods are in the first line of choice. Hormone containing contraceptives do not affect the composition of milk, minerals (Mg, Fe, Cu, Ca, P) fat, lactose and calories but only a few the proteins.

Ethinyl estradiol while Breastfeeding

Low Risk

CAS Number: 57-63-6

Synthetic estrogen that has a similar action as estradiol. Used in combination with progestogens for contraception. Ethinylestradiol is excreted in small or no amount into breast milk.There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of ethinyl estradiol.It may reduce the protein content of the milk.No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. During lactation progestin-only drugs are preferred or in combination with estrogen for birth control, but whatever, the ones with the lower doses of estrogen should be used.For the first 6 weeks postpartum, non-hormonal methods are of choise.


Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit Breastfeeding Analsys - 2


Drospirenone while Breastfeeding

CAS Number: 67392-87-4

Drospirenone is a progestin that is an analogue of spironolactone. It has antimineralocorticoid and antiandrogenic activities and is available in the U.S. only in combination with ethinyl estradiol as an oral contraceptive agent. Based on the available evidence, expert opinion holds that nonhormonal methods are preferred during breastfeeding and progestin-only contraceptive are preferred over combined oral contraceptives in breastfeeding women, especially during the first 4 weeks postpartum. For further information, consult the record entitled, "Contraceptives, Oral, Combined."

Ethinyl estradiol while Breastfeeding

CAS Number: 57-63-6

This record contains information specific to ethinyl estradiol used alone. Users with an interest in an oral contraceptive should consult the record entitled, "Contraceptives, Oral, Combined."There is little information available on the use of ethinyl estradiol alone during breastfeeding. Levels in milk appear to be low. Based on studies on oral contraceptives that contain ethinyl estradiol, immediate side effects such as breast enlargement appear to occur rarely. It seems likely that doses of 30 mcg daily or greater can suppress lactation. The magnitude of the effect on lactation likely depends on the dose and the time of introduction postpartum, but data are not adequate to accurately define these doses and times.



What should I do if already breastfed my kid after using Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit?

Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit so you should inform him based on your convenience.


My health care provider has asked me to use Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit, what to do?

Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit, will my baby need extra monitoring?

Not much monitoring required while using Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit


Who can I talk to if I have questions about usage of Lo-zumandimine | Drospirenone And Ethinyl Estradiol Kit in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients